- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/775 - Apolipopeptides
Détention brevets de la classe C07K 14/775
Brevets de cette classe: 626
Historique des publications depuis 10 ans
|
39
|
25
|
35
|
41
|
36
|
35
|
24
|
31
|
38
|
40
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 20230 |
27 |
| CSL Limited | 255 |
17 |
| ABIONYX Pharma SA | 47 |
15 |
| F. Hoffmann-La Roche AG | 7932 |
10 |
| Lawrence Livermore National Security, LLC | 1940 |
10 |
| Cornell University | 3348 |
10 |
| Children's Medical Center Corporation | 1906 |
9 |
| Cerenis Therapeutics Holding SA | 25 |
8 |
| University of Cincinnati | 888 |
8 |
| The General Hospital Corporation | 4792 |
7 |
| Cleveland HeartLab, Inc. | 23 |
7 |
| Indiana University Research and Technology Corporation | 799 |
7 |
| The Jackson Laboratory | 351 |
7 |
| Theripion, Inc. | 17 |
7 |
| Centre National de La Recherche Scientifique | 10635 |
6 |
| Toray Industries, Inc. | 7004 |
6 |
| Duke University | 3103 |
6 |
| Northwestern University | 3442 |
6 |
| Alnylam Pharmaceuticals, Inc. | 1140 |
6 |
| National Cancer Center | 426 |
6 |
| Autres propriétaires | 441 |